{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:28:22Z","timestamp":1792643302485,"version":"4.5.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186422","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T13:45:47Z","timestamp":1508420747000},"page":"e0186422","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-1179","authenticated-orcid":true,"given":"Kuo-Shao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Chih-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"FS Taccone","year":"2015","journal-title":"Critical care (London, England)"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s15010-013-0539-3","article-title":"SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients","volume":"42","author":"MT Montagna","year":"2014","journal-title":"Infection"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e0156566","DOI":"10.1371\/journal.pone.0156566","article-title":"Correction: Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan","volume":"11","author":"KS Sun","year":"2016","journal-title":"PloS one"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13054-014-0458-4","article-title":"How to manage aspergillosis in non-neutropenic intensive care unit patients","volume":"18","author":"M Bassetti","year":"2014","journal-title":"Critical care (London, England)"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1086\/592255","article-title":"Factors associated with overall and attributable mortality in invasive aspergillosis","volume":"47","author":"Y Nivoix","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","article-title":"Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States","volume":"54","author":"A Kim","year":"2011","journal-title":"Mycoses"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes","volume":"13","author":"JW Baddley","year":"2013","journal-title":"BMC infectious diseases"},{"key":"ref8","article-title":"Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries","author":"R Porpon","year":"2017","journal-title":"Medical mycology"},{"issue":"3","key":"ref9","first-page":"149","article-title":"Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units","volume":"39","author":"F Alvarez Lerma","year":"2015","journal-title":"Medicina intensiva"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"WJ Steinbach","year":"2012","journal-title":"The Journal of infection"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"AJ Ullmann","year":"2007","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"J Maertens","year":"2005","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"BH Tan","year":"2011","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"D Bitar","year":"2014","journal-title":"Emerging infectious diseases"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10096-011-1445-1","article-title":"Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000\u20132009","volume":"31","author":"HC Hsiue","year":"2012","journal-title":"European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"e000155","DOI":"10.1136\/bmjresp-2016-000155","article-title":"Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan","volume":"3","author":"N Iqbal","year":"2016","journal-title":"BMJ open respiratory research"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/528714","article-title":"Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications","volume":"46","author":"MH Miceli","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12879-015-1014-9","article-title":"Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis","volume":"15","author":"SB Han","year":"2015","journal-title":"BMC infectious diseases"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s15010-008-7375-x","article-title":"Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases","volume":"36","author":"S Gallien","year":"2008","journal-title":"Infection"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4236\/aim.2015.55029","article-title":"Invasive Aspergillus Infections in a Thai Tertiary-Care Hospital during 2006\u20132011","volume":"5","author":"A Thammahong","year":"2015","journal-title":"Advances in Microbiology"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","article-title":"Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis","volume":"37","author":"G Burghi","year":"2011","journal-title":"Intensive Care Med"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","article-title":"Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence","volume":"56","author":"KH Vandewoude","journal-title":"Journal of Hospital Infection"},{"issue":"3","key":"ref23","first-page":"269","article-title":"Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance(R) registry analysis","volume":"55","author":"S Husain","year":"2017","journal-title":"Medical mycology"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijantimicag.2010.08.010","article-title":"The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and\/or immunosuppressed patients","volume":"36","author":"S Perkhofer","year":"2010","journal-title":"International journal of antimicrobial agents"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"B De Pauw","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:45:41Z","timestamp":1540032341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186422"}},"subtitle":[],"editor":[{"given":"William C.","family":"Nierman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186422","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}